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Abstract

in a 23 year old female and a corresponding review of literature.

Teratocarcinosarcoma is a rare, morphologically
heterogeneous and highly malignant neoplasm. It is
characterized by the presence of benign and malignant
epithelial, mesenchymal and neural components. The
carcinoma may be either squamous or adenocarcinoma and
the mesenchymal component may manifest spindle, smooth,
skeletal muscle, cartilage and bone features. Because of their
infrequency, these lesions are often misdiagnosed, leading to
management difficulties. In this case report we have shared
our experience with sinonasal teratocarcinosarcoma in a 23
year old female and performed a brief review of literature.

Case Report

Keywords: Sinonasal etratocarcinosarcoma, Pakistan,
Malignant.

Introduction
Sinonasal teratocarcinosarcoma (STCS) is an
extremely rare malignant tumour, thought to arise exclusively
in the sinonasal tract. It was first described by
Shanmugaratnamin 1983 as teratoidcarcinosarcoma,1
consisting of various components of neuroectodermal,
epithelial and mesenchymal proliferations of varying
maturity. Keeping its complex cyto-architecture in mind the
tumour was later named as sinonasalteratocarcinosarcoma by
Heffner et al in 1984, after their review of 20 cases.2 The
tissue heterogeneity usually leads to misdiagnosis especially
where limited sampling is carried out. Of the 20 cases
reviewed by Heffner, many were mislabeled as
adenocarcinoma, olfactory neuroblastoma, fibrosarcoma and
rhabdomyosarcoma.2
A review of literature by the authors found 88 cases of
this tumour, as case reports and short series, associated with
loco-regional recurrence and highmortality. One of the larger
series calculated a two year disease free survival rate of 28%
and the overall survival rate of 46%.3 However, most of the
literature deals with histopathological findings and tissue
architecture of the tumour leaving a void with respect to clinical
findings, management and treatment outcomes.3 Due to the
rarity of this condition management guidelines are currently
unavailable and management is tailored to suit the patient. Here
we present our first experience sinonasalteratocarcinosarcoma
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A 23 year old female presented to our
Otorhinolaryngology clinic with complaints of a mass
protruding from her right nostril. She was in her usual state of
health four months ago when she started experiencing nasal
obstruction and epistaxis. Within a matter of days, she
developed a mass protruding out of her right nostril, which
was partially excised at another center intranasally.
Histopathological examination revealed STCS (Figure-1).
Fifteen days after its excision the mass reappeared.
On examination a reddish growth was seen protruding
from her right nasal cavity, completely obstructing the right
nostril.The mass was soft, friable, and fleshy in appearance.
On the external aspect the mass was approximately 1.5 x
1.5cm; however clinical assessment of its size could not be
conducted as the bulk of the tumour was within the nasal
cavity and paranasal sinuses.Magnetic resonance
imaging(MRI) with contrast showed a large exophytic mass
involving the right nasal cavity. The mass was bulging
posteriorly almost obliterating the nasopharyngeal space.
Superiorly it was involving the ethmoid air cells and was

Figure-1: Teratocarcinosarcoma of the nasal cavity showing an admixture of wellformed glands with atypical epithelium alongwith sarcomatous areas and primitive
neuroepithelium with rosettes. (H&E,4X).
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The patient remained under regular follow up for last 6
months, with no recurrence.

Discussion

Figure-2: Sagittal MRI of the patient showing a large exophytic mass inthe right
nasal cavity, bulging posteriorly and almost completely obliterating the
nasopharyngeal lumen.

closely adherent to dura; however no dural breach was noted.
Significant obstruction of the right maxillary sinus and
sphenoid sinus bilaterally leading to mucosal thickening and
fluid retention was also seen (Fiture-2). There was no cervical
lymphadenopathy.
A right lateral rhinotomy and maxillectomy was
performed and the tumour was excised. An attempt was made
to remove mass in a single piece. However, near the dura it
was removed in a piece meal fashion with the help of an
operating microscope (Carl ziess; Neurosurgical adjustable
microscope, upto 400 magnification). This careful piece meal
removal was done to avoid disruption of the dura. Bleeding
was moderate during surgery and multiple bleeders were
identified which were controlled using bipolar cautery. Near
dura adrenaline soaked patties were also used along with
bipolar cautery. Estimated intraoperative bleeding was
around 200 ml. The mass was adherent to nasal septum,
maxillary and ethmoid sinus walls making it difficult to
ascertain the site of origin. During the excision the patient
developed a dural tear near the cribriform plate, which was
repaired by our neurosurgical service by intranasal route. Post
operative bilateral anterior nasal packing with bismuth iodine
paraffin paste was done and a lumbar drain was also placed.
Her postoperative recovery was unremarkable with no need
of blood transfusions. The nasal packs were removed after 48
hours and the lumbar drain was removed on the 3rd
postoperative day following which she was discharged.
She was planned for concurrent chemo-radiotherapy
and six cycles of Cisplatin (20 mg/m2 days) and
Etoposide(100 mg /m2 days) with 35 fractions of radiation
(external beam radiation using bi-linear accelerator, upto 70
Gy) were given. An excellent clinical response was achieved.
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Sinonasal teratocarcinosarcoma is thought to arise
from the pluripotent olfactory epithelial cells in the nasal
cavity. However, some ambiguity exists regarding the cells of
origin. Most authors agree that a pluripotential progenitor cell
with multidirectional differentiation capabilities is the most
likely case giving rise to the complex cyto-architecture and
tissue heterogeneity.4,5 The tumour is composed of neural,
epithelial and mesenchymal neoplastic tissue in varying
degrees of maturity. Due to the presence of multiple cell lines
STCS may mimic other pathologies derived from those cells,
depending upon the predominant tissue obtained at biopsy.
Limited biopsy samples may therefore fail to establish any
diagnosis. The presence of foetal squamous cells which
exhibit clear cytoplasm is however, considered a
pathognomic histological feature of the disease.
These highly malignant tumours initially present with
relatively benign complaints of recurrent epistaxis (53.52%
of cases) and nasal obstruction (61.97% of cases). Other
manifestations raising suspicions of malignancy, such as
odynophagia, dysphagia, expectoration of tissue, epiphora,
headache, vision loss, exophthalmos, anosmia and altered
mental status arise when the tumour invades surrounding
tissues and the severity if related to the degree of tumour
extension.4 Cases of patients presenting with syndrome of
inappropriate anti diuretic hormone secretion (SIADH) have
also been reported.4,6 In our analysis of available literature
these symptoms presented within a short mean duration of
102 days, which could be attributed to the aggressive nature
of the tumour.
On nasal examination a moderately firm red or
reddish-purple mass may be visualized with friable and
necrotic areas; manipulation of the mass may lead to
epistaxis.7 The findings were consistent with our case with a
red-coloured mass protruding from the nasal cavity which
bled on examination/manipulation. Most common sites
involved are the nasal cavity and paranasal sinuses. Bone
erosion and intracranial extension were also noted in 24.19%
and 20.96% of the reported cases at the time of presentation
respectively.
Analysis of the available literature on STCS showed a
strong male predominance with an average age of
presentation at about 51.75 years. However of interest is that
our patient was the third reported patient under the age of 25,
while the other two cases arose from India,8,9 indicating that
a common environmental or genetic link for an early age of
onset of this disease.
Currently no management guidelines are available
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regarding the disease and most of the literature focuses on the
histo-pathological findings. Clinical details were available for
about half of the reported cases, analysis of which revealed
that 87.14% of cases underwent aggressive surgical excision
followed by adjuvant radiotherapy in 60.00%. About 11.42%
of patients also underwent adjuvant chemo/radiotherapy postsurgically. However local recurrence after excision is high
with reported 3 and 5 year survival rates at about 30% and
20%, respectively.10 In our analysis of literature we found
recurrence in 42.68% of the cases with a mean recurrence
time of 21.3 months in patients followed for a mean period of
76.1 months.
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